We are live on
!
Find out more
10x Genomics
TXG
TXG
329 hedge funds and large institutions have $2.66B invested in 10x Genomics in 2026 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 115 increasing their positions, 102 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
13% more repeat investments, than reductions
Existing positions increased: 115 | Existing positions reduced: 102
2% more funds holding
Funds holding: 322 → 329 (+7)
0.26% more ownership
Funds ownership: 106.12% → 106.38% (+0.26%)
Holders
329
Holding in Top 10
7
Calls
$23.6M
Puts
$1.61M
Top Buyers
| 1 | +$116M | |
| 2 | +$21.8M | |
| 3 | +$19.8M | |
| 4 |
Goldman Sachs
New York
|
+$17.7M |
| 5 |
CC
Casdin Capital
New York
|
+$17.5M |
Top Sellers
| 1 | -$23.6M | |
| 2 | -$19M | |
| 3 | -$17.5M | |
| 4 |
Two Sigma Investments
New York
|
-$15.1M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$14.6M |
